• 1
    Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2009 (Update). [Accessed: 5 Aug 2011.] Available from URL:
  • 2
    British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Revised in May 2011. [Accessed: 5 Aug 2011.] Available from URL:
  • 3
    Qaseem A, Snow V, Shekelle P et al. Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann. Intern. Med. 2007; 147: 6338.
  • 4
    Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids: new developments. Am. J. Respir. Crit. Care Med. 1998; 157(3 Pt 2): S1S53.
  • 5
    Allen DB. Safety of inhaled corticosteroids in children. Pediatr. Pulmonol. 2002; 33: 20820.
  • 6
    Singh S, Amin AV, Loke YK. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease. A meta-analysis. Arch. Intern. Med. 2009; 169: 21929.
  • 7
    Drummond MB, Dasenbrrok EC, Pitz MW et al. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008; 300: 240716.
  • 8
    O'Byrne PM, Pedersen S, Carlsson L et al. Risks of pneumonia in patients with asthma taking inhaled corticosteroids. Am. J. Respir. Crit. Care Med. 2011; 183: 58995.
  • 9
    Fukushima C, Matsuse H, Saeki S et al. Salivary IgA and oral Candidiasis in asthmatic patients treated with inhaled corticosteroid. J. Asthma 2005; 42: 601 4 .
  • 10
    Bateman ED, Hurd SS, Barnes PJ et al. Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J. 2008; 31: 14378.
  • 11
    National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Test; Approved Standard-8th Edition. NCCLS Document M2-A8. The Institute, Wayne, PA, 2003.
  • 12
    Bogaert D, de Groot R, Hermans PWM. Streptococcus pneumoniae colonization: the key to pneumococcal disease. Lancet Infect. Dis. 2004; 4: 14454.
  • 13
    Hakansson A, Carlstedt I, Davies J et al. Aspects on the interaction of Streptococcus pneumoniae and Haemophilus influenzae with human respiratory tract mucosa. Am. J. Respir. Crit. Care Med. 1996; 154(4 Pt2): S1879.
  • 14
    García-Rodríguez JA, Martinez MJF. Dynamics of nasopharyngeal colonization by potential respiratory pathogens. J. Antimicrob. Chemother. 2002; 50(Suppl. S2): 5973.
  • 15
    Jounio U, Juvonen R, Bloigu A et al. Pneumococcal carriage is more common in asthmatic than in non-asthmatic young men. Clin. Respir. J. 2010; 4: 2229.
  • 16
    Talbot TR, Hartert TV, Mitchel E et al. Asthma as a risk factor for invasive pneumococcal disease. N. Engl. J. Med. 2005; 352: 208290.
  • 17
    Marrie TJ. Pneumococcal pneumonia: epidemiology and clinical features. Semin. Respir. Infect. 1999; 14: 22736.
  • 18
    Baquero F, Baquero-Artigao G, Cantón R et al. Antibiotic consumption and resistance selection in Streptococcus pneumoniae. J. Antimicrob. Chemother. 2002; 50(Suppl. S2): 27 37 .
  • 19
    Albrich WC, Monnet DL, Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg. Infect. Dis. 2004; 10: 5147.
  • 20
    Lieberman D, Shleyfer E, Castel H et al. Nasopharyngeal versus oropharyngeal sampling for isolation of potential respiratory pathogens in adults. J. Clin. Microbiol. 2006; 44: 52558.
  • 21
    D'Avila NE, Zhang L, Miller RG et al. High prevalence of nasopharyngeal colonization by Staphylococcus aureus among children with HIV-1 infection in extreme southern Brazil. J. Trop. Pediatr. 2008; 54: 4102.